Independence Valued Over Survival for Neuroendocrine Tumor Patients
FRIDAY, Dec. 30, 2022 (HealthDay News) -- Independence is valued over survival among adult patients with neuroendocrine tumors (NETs), according to a study published in the December issue of the Journal of the National Comprehensive Cancer Network. Daneng Li, M.D., from City of Hope in Duarte, California, and colleagues examined patient values toward treatment goals